PAR-18-437 - Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders NOT-DA-21-006 NIDA Apr 30, 2021 Sep 8, 2024 R01, R03, R21, 333
Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes NOT-DA-20-018 NIDA Mar 25, 2020 Sep 8, 2023 R01, R03, R21, 333
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders NOT-DA-20-021 NIDA Mar 25, 2020 Sep 8, 2023 R01, R03, R21, K99/R00, R61/R33
For technical issues E-mail OER Webmaster